Goldman Sachs invests in Aragen Life Sciences
These shares were previously held by ChrysCapital and other existing shareholders
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Goldman Sachs
Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs
Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion